Analyse Bayer stock

Confirmed: The consensus price target of 49.40 EUR is only around -7.4% below the current price of 53.36 EUR and is therefore clearly within the required plausibility range of ±25%.

Quantitative: The price is trading close to the 52-week high (53.92 EUR) after a very strong recovery from the 52-week low (24.81 EUR); Technically, this suggests that the re-rating has already been largely priced in and limits further upside potential in the short term. The stated P/E ratio of 23.15 does not seem favorable enough for Bayer to justify a significantly higher target, especially since debt, legal risks and cyclical uncertainties i...